Grant funding

Showing   of 56 results

Thumbnail image of female doctor looking at brain scans.

National Institute on Aging Awards Expected to Total $21.1 Million to Renew Support for Cleveland Alzheimer’s Disease Research Center

Center is one of 37 NIH-funded Alzheimer’s Disease Research Centers in the nation.

University Hospitals Awarded Historic $56.25 Million HRSA Grant to Lead New Pediatric Prevention Network

Largest federal grant in UH history will strengthen the nation's ability to protect children before, during, and after disasters and public health emergencies.

University Hospitals and Case Western Reserve University School of Medicine Fund Six Research Teams through the 2026 Collaborative Science Pilot Awards

Program emphasizes mentorship between junior investigators and established researchers.

Harrington Discovery Institute Announces 2026 Scholar-Innovator Award Recipients

Drug development grant will advance 10 physician-scientists’ discoveries toward the clinic.

Harrington Discovery Institute Opens Call for 2027 Harrington Scholar-Innovator Award

Unique program for physician-scientists to advance promising discoveries into medicines.

Thumbnail image of Exterior view of Harrington Discovery Institute from Ford Drive.

Harrington Discovery Institute at University Hospitals and Case Western Reserve School of Medicine Open Call for 2026 Harrington-MSTP Scholar Award

Grant award provides MD/PhD candidates with funding and expertise to translate promising scientific discoveries into medicines.

Thumbnail image of Dr. Peter Pronovost and Dr. Patrick Runnels.

University Hospitals Receives a $2.3 Million Grant from the John Templeton Foundation

The grant will support the project titled “Transforming Healthcare through the Power of Love: Expanding and Spreading the 'Living and Leading with Love' Framework”

Thumbnail image of Dr. John Letterio.

David’s Warriors St. Baldrick’s Research Grant Awarded to UH Rainbow Physician Researcher for Pediatric Neuroblastoma Study

The grant will support Dr. John Letterio’s project titled, “Development of a Novel NF-κB Targeting Agent for Pediatric Neuroblastoma” focused on improving treatment outcomes for children with high-risk neuroblastoma.

Results are loading...